Amsel Medical
James Heinz, MSL, is currently the Sr. Vice President Strategic Development at Amsel Medical and also serves on the Amsel Advisory Board. James A. is the Founder & CEO of the Center for Venous Disease, established in 2005. Previously, James A. worked as a Sr. Territory Manager for VNUS Medical Technologies / Covidian / Medtronic. James A. obtained their Master of Science in Organizational Leadership from Grand Canyon University in 2017.
This person is not in any teams
Amsel Medical
This unique mechanical surgical clamping technology is delivered directly through a fine, minimally invasively, 18 G needle for clamping of blood vessels, ducts, arteries, and veins. The minimally invasive needle delivery results in secure occlusion similar to that of a transfixion suture. SCureClamp with iDOT’s anchoring feature secures the implant in place and eliminates slippage. Grasping allows physicians to occlude vessels of varying sizes, types, and wall thickness.